ELCC 2018: News & Press Releases

Keep up to date with all the news and press releases from the ELCC 2018 European Lung Cancer Congress

Filter

Date Title Topic
13 Apr 2018 ELCC 2018 News: New Data Support First-Line Osimertinib in Patients with NSCLC and Sensitising EGFR Mutation Lung and other thoracic tumours - Personalised medicine - Anticancer agents & Biologic therapy
13 Apr 2018 ELCC 2018 News: Low Baseline Endoglin Levels May Signal Improved Survival with Nintedanib in Malignant Pleural Mesothelioma Lung and other thoracic tumours - Translational research - Anticancer agents & Biologic therapy
12 Apr 2018 Coordinating Nurses can Improve Cancer Patients’ Quality of Life and Satisfaction During Treatment [ELCC 2018 Press Release] Lung and other thoracic tumours
12 Apr 2018 ELCC 2018 News: Second-line TKI Therapy Demonstrates Clinical Benefit in Patients with EGFR Mutated NSCLC and Leptomeningeal Metastasis Lung and other thoracic tumours - Personalised medicine - Anticancer agents & Biologic therapy
12 Apr 2018 ELCC 2018 News: Patients with Advanced Lung Adenocarcinoma and Complex EGFR Mutations Demonstrate Different Response Rates to TKI Therapy Lung and other thoracic tumours - Personalised medicine - Anticancer agents & Biologic therapy
12 Apr 2018 Further Evidence that Immunotherapy Provides a Long-term Survival Benefit for Lung Cancer Patients [ELCC 2018 Press Release] Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
12 Apr 2018 Alectinib Provides Longer Symptom Improvement than Crizotinib in ALK-positive Lung Cancer [ELCC 2018 Press Release] Lung and other thoracic tumours
27 Mar 2018 ELCC 2018 Press Release: Heine H. Hansen Award Given to Fabrice Barlesi Lung and other thoracic tumours